These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33667588)

  • 1. Increasing neutrophil-to-lymphocyte ratio following radiation is a poor prognostic factor and directly correlates with splenic radiation dose in pancreatic cancer.
    Wolfe AR; Siedow M; Nalin A; DiCostanzo D; Miller ED; Diaz DA; Arnett A; Cloyd JM; Dillhoff M; Ejaz A; Tsung A; Williams TM
    Radiother Oncol; 2021 May; 158():207-214. PubMed ID: 33667588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of neutrophil-to-lymphocyte ratio change in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy.
    Yin X; Chen H; Sun Y; Xiao L; Lu H; Guo W; Yang H; Zhou J; Fan K; Liang W
    Sci Rep; 2024 May; 14(1):11984. PubMed ID: 38796631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Neutrophil to Lymphocyte Ratio Dynamics in Patients with Hepatocellular Carcinoma Treated with Radioembolization Using Glass Microspheres.
    Li X; Montazeri SA; Paz-Fumagalli R; Padula CA; Wang W; Mody K; Roberts LR; Patel T; Krishnan S; Toskich B
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2624-2634. PubMed ID: 33438101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy.
    Reddy AV; Deek MP; Jackson JF; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
    Radiat Oncol; 2021 Dec; 16(1):242. PubMed ID: 34952610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cancer.
    Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
    J Gastrointest Oncol; 2022 Feb; 13(1):368-379. PubMed ID: 35284125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer.
    Jin F; Han A; Shi F; Kong L; Yu J
    Onco Targets Ther; 2016; 9():6529-6537. PubMed ID: 27799800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma.
    Chen Y; Yan H; Wang Y; Shi Y; Dai G
    Sci Rep; 2017 Apr; 7(1):753. PubMed ID: 28392554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
    Chadha AS; Liu G; Chen HC; Das P; Minsky BD; Mahmood U; Delclos ME; Suh Y; Sawakuchi GO; Beddar S; Katz MH; Fleming JB; Javle MM; Varadhachary GR; Wolff RA; Crane CH; Wang X; Thames H; Krishnan S
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):323-332. PubMed ID: 28068240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative to postoperative change in neutrophil-to-lymphocyte ratio predict survival in colorectal cancer patients.
    Guo D; Han A; Jing W; Chen D; Jin F; Li M; Kong L; Yu J
    Future Oncol; 2018 May; 14(12):1187-1196. PubMed ID: 29302993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The post-treatment neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after treatment of stage III non-small-cell lung cancer with conventionally fractionated radiotherapy.
    Wang D; Guo D; Li A; Wang P; Teng F; Yu J
    Future Oncol; 2020 Mar; 16(9):439-449. PubMed ID: 32141321
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Significance of Dynamic Neutrophil-lymphocyte Ratio Changes in Patients With Colorectal Cancer.
    Ashizawa N; Furuya S; Katsutoshi S; Sudo M; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Inoue S; Kono H; Ichikawa D
    Anticancer Res; 2020 Apr; 40(4):2311-2317. PubMed ID: 32234931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the neutrophil to lymphocyte ratio as predictors of outcome in pediatric patients with central nervous system tumors undergoing surgical resection.
    Flores-Bustamante A; Hernández-Regino L; Castillejos-López MD; Martínez-Rodríguez D; Aquino-Gálvez A; Zapata-Tarrés M; de Uña-Flores A; Salinas-Lara C; Sierra-Vargas P; Torres-Espíndola LM
    Cancer Biomark; 2022; 33(3):291-298. PubMed ID: 34511483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative Elevations of Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios Predict Postoperative Pulmonary Complications in Non-small Cell Lung Cancer Patients: A Retrospective Cohort Study.
    Wang Y; Hu X; Su MC; Wang YW; Che GW
    Curr Med Sci; 2020 Apr; 40(2):339-347. PubMed ID: 32337695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of neutrophil-to-lymphocyte ratio dynamics in patients with septic acute kidney injury: a cohort study.
    Wei W; Liu C; Song G; Yang L; Li J; Wang B; Yin T; Yang Y; Ma L; Zhang L; Fu P; Zhao Y
    Ren Fail; 2024 Dec; 46(1):2343818. PubMed ID: 38637281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 inhibitors.
    Chen S; Li R; Zhang Z; Huang Z; Cui P; Jia W; Zhang S; Tao H; Wang L; Li X; Wang J; Ma J; Liu Z; Huang D; Zheng X; Saito Y; Ichiki Y; Hu Y
    Transl Lung Cancer Res; 2021 Mar; 10(3):1397-1407. PubMed ID: 33889518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
    Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R
    Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma.
    Guida M; Bartolomeo N; Quaresmini D; Quaglino P; Madonna G; Pigozzo J; Di Giacomo AM; Minisini AM; Tucci M; Spagnolo F; Occelli M; Ridolfi L; Queirolo P; De Risi I; Valente M; Sciacovelli AM; Chiarion Sileni V; Ascierto PA; Stigliano L; Strippoli S
    J Transl Med; 2022 Apr; 20(1):159. PubMed ID: 35382857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of neutrophil-lymphocyte ratio is superior to derived neutrophil-lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up.
    Jin H; Sun J; Zhu K; Liu X; Zhang Q; Shen Q; Gao Y; Yu J
    Onco Targets Ther; 2017; 10():2655-2664. PubMed ID: 28579803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.